The limitation of this study includes that our investigation focused solely on c-Jun-miR-193b-3p-PrPc axis in lung cancer, which may not fully capture the broader context in which other miRNAs and/or regulatory mechanisms could also be involved in modulating PrPc expression. The gene discussed is JUN; the disease is lung carcinoma.